Press / Media

 

Annual Reports Fraunhofer IME

Focus on people


At Fraunhofer, people are the focus of research. Prof. Fischer, former Head of the Fraunhofer Institute for Microbiology and Applied Ecology IME and Prof. Weissenberger-Eibl, Head of the Fraunhofer Institute for Systems and Innovation Research ISI, wrote a joint article on this guiding principle. Read the main contribution in the annual report 2015 of the Fraunhofer-Gesellschaft, starting on page 61.

 

Publication Lists

Cancel
  • License Agreement with LenioBio

    Molecular Biotechnology / 1.8.2018

    Life sciences startup LenioBio GmbH and the Fraunhofer IME announced today the signing of an exclusive license agreement that allows LenioBio to utilize Fraunhofer’s proprietary vector solution and technology for the cryopreservation of cell-free lysates. The optimized vector solution and cryopreservation technology from Fraunhofer IME has been specifically developed to meet the wide application areas LenioBio is targeting. With the addition of the Fraunhofer IME license, LenioBio is extending the patent family covering this innovative cell-free system.

    more info
  • Jacobs University and Fraunhofer IME signed MoU

    Translational Medicine / 11.6.2018

    Jacobs University Bremen and the Fraunhofer Institute for Molecular Biology and Applied Ecology IME, today announce their intention to set up a new strategic collaboration to establish joint research projects in the area of antibiotic drug discovery and promote the exchange of students, researchers and educators between the institutions.

    more info
  • Plants for pharmaceutical industry 4.0

    Molecular Biotechnology / 9.5.2018

    The Fraunhofer IME presented a living exhibit and it`s digital twin at the joint Fraunhofer booth “Future Factory” at the Hanover Trade Fair 2018.

    more info
  • The Fraunhofer Institute for Molecular Biology and Applied Ecology IME participates in the EU-funded NEWCOTIANA project a research and innovation action that combines several new plant breeding techniques to produce medical and cosmetic products in plants.

    more info
  • The interdisciplinary consortium HiPSTAR tries to decipher the molecular mechanisms leading to Morbus Alzheimer. In particular, pathological alterations at the blood-brain-barrier are in the focus of this applied research project. The long-term goal of this collaborative effort is the development of new drugs and therapies targeting this predominant form of dementia. The project is coordinated by the University of Würzburg (Medical Faculty, Department of Tissue Engineering and Regenerative Medicine, TERM), and the Fraunhofer Institute for Molecular Biology and Applied Ecology, ScreeningPort, is a partner in the consortium. The German Ministry for Education and Research (Bundesministerium für Bildung und Forschung, BMBF) funds this project with an overall budget of 1.7 million Euro.

    more info
  • Hamburg. Human stem cells, which can be produced from mature cells by dialing back their developmental programming - so-called "induced pluripotent stem cells (iPS cells)" - have enormous potential for regenerative medicine as well as for the research and development of new therapeutics. To ensure the development of better drug candidates in the field of patient-derived iPS cells, Evotec AG and the Fraunhofer Institute for Molecular Biology and Applied Ecology IME are entering into a strategic alliance.

    more info
  • Los Angeles, CA, Fraunhofer IME, Uskudar University , the Society for Brain Mapping and Therapeutics (SBMT), Brain Mapping Foundation (BMF), National Center for NanoBioElectronic (NCNBE) have come together in Hamburg, Germany during the G20 Summit to expand global cooperation and partnership on clinical translational neuroscience through Neuroscience-20 (N20) Initiative. The scientists call for global collaboration, partnership, data-sharing, and more allocation of funds to combat enormous economical and human costs of neurological disorders world wide

    more info
  • Strategic collaboration between Hamburg and Groningen: In order to facilitate drug discovery and biomarker development within the theme Healthy Ageing, Fraunhofer IME ScreeningPort (Hamburg) and the European Research Institute for the Biology of Ageing ERIBA (University Medical Center Groningen, University of Groningen), have formed a strategic alliance. The initiative is supported by grants from the cities of Hamburg and Groningen.

    more info
  • South America is fighting a battle against tiger mosquitoes that transmit yellow fever, dengue fever and the Zika virus. In Central Europe, wine and fruit growers fear another year of massive crop failures due to a type of vinegar fly known as the spotted-wing drosophila. Since the success rate of conventional methods continues to fall, researchers from Fraunhofer and the Justus-Liebig-University Gießen are developing new species-specific strategies that keep pests under control without resorting to environmental toxins.

    more info
  • La Jolla, CA, Kiel, Hamburg – Researchers at The Scripps Research Institute (TSRI) in California, USA, and two German institutes, the Center for Integrated Psychiatry Kiel (ZIP) and the Fraunhofer Institute for Molecular Biology and Applied Ecology IME, have announced a partnership to advance the quality control of human stem cells. Scientists now routinely create »induced pluripotent stem cells«, called iPSCs, which have enormous potential for regenerative medicine, research, and development of new therapeutic agents. To assure that high quality iPSCs are available for research and clinical use, the collaborators are developing rigorous new genomics-based methods to analyze the cells.

    more info